Sort
23,748 grants matching “melanoma”
Targeting CCR2-expressing myeloid cells to overcome immune checkpoint inhibitor resistance in glioma
$378,934Jeffrey K Harrison · University Of Florida · R01 · FY2019 · NS
Function and Regulation of the BCL-2 Family
$378,858Jerry Edward Chipuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · CA
Function and Regulation of the BCL-2 Family
$378,858Jerry Edward Chipuk · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · CA
Winship Cancer Institute, Emory University
$378,807Paul W. Doetsch · Emory University · P20 · FY2007 · CA
Role of Mononuclear Leukocytes in Immunity
$378,805Samuel Charles Silverstein · Columbia University Health Sciences · R01 · FY2008 · AI
Mechanisms of Immune Evasion by Ocular Tumors
$378,750Kyle C McKenna · University Of Pittsburgh At Pittsburgh · R01 · FY2008 · EY
Mechanisms of Immune Evasion by Ocular Tumors
$378,750Kyle C McKenna · University Of Pittsburgh At Pittsburgh · R01 · FY2009 · EY
Signaling importance of âfunctionlessâ lyso-PAF, an inactive form of platelet activating factor, in melanoma with mutant Nras
$378,725Jing Chen · University Of Chicago · R01 · FY2024 · CA
Taming two bacterial toxins into an anticancer agent with "sweets"
$378,675Chen Chen · Louisiana State Univ A&M Col Baton Rouge · R21 · FY2024 · CA
Host Defense and the Regulation of Interferon Production
$378,675Glen N. Barber · University Of Miami School Of Medicine · R01 · FY2010 · AI
Structural Biology of GTPase Activating Proteins
$378,671R Byrd · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
$378,575Guizhi Zhu · University Of Michigan At Ann Arbor · R01 · FY2024 · CA
Novel Biosynthetic Pathway for Secosteroids and the Skin
$378,519Andrzej T Slominski · University Of Tennessee Health Sci Ctr · R01 · FY2008 · AR
Microcirculation of Uveal Melanoma
$378,487Robert Folberg · University Of Illinois At Chicago · R01 · FY2006 · EY
Administrative Core
$378,467James R. Heath · Institute For Systems Biology · U54 · FY2023 · CA
Personalized targeting of anti-apoptosis pathways to overcome therapeutic resistance in melanoma
$378,415Michael Davies · Wistar Institute · U54 · FY2024 · CA
ELUCIDATION & MODULATION OF NATURAL KILLER CELL SIGNALING: APPLICATION IN CANCER
$378,367Michael A Caligiuri · Ohio State University · P01 · FY2007 · CA
CLASS II ANTIGEN PRESENTATION VIA CHAPERONE MEDIATED AUTOPHAGY
$378,349Janice S Blum · Indiana University Indianapolis · R01 · FY2013 · AI
Development and Mechanistic Studies of an Engineered Human Enzyme to Abrogate Immune Suppression due to Elevated Methylthioadenosine (MTA) by MTAP null/low Tumors
$378,348Everett Stone · University Of Texas At Austin · R01 · FY2021 · CA
BIOLOGY OF SIALIC ACIDS AND THEIR SUBSTITUTIONS
$378,325University Of California San Diego · R37 · FY2003 · GM
Controlled Release of Macromolecules
$378,300Robert S Langer · Massachusetts Institute Of Technology · R37 · FY2014 · EB
Targeting the immunosuppressive adenosine-axis to overcome T-cell γc cytokine signaling blockade and enhance antitumor immunity in hepatocellular carcinoma
$378,246Yong Qin · University Of Texas El Paso · U54 · FY2025 · MD
Targeting the liver for immunotherapy in pancreatic cancer
$378,219Gregory L Beatty · University Of Pennsylvania · R01 · FY2023 · CA
The Role of Stromal Autophagy in Cutaneous Melanoma
$378,218Hilary A Coller · University Of California Los Angeles · R01 · FY2018 · CA
USP18 in Cancer Development
$378,186Dong-Er Zhang · University Of California, San Diego · R01 · FY2021 · CA